Oxidant stress and skeletal muscle microvasculopathy in the metabolic syndrome

Vascular Pharmacology

Volumn 57, Issue 5-6, 2012, Pages 150-159

  Goodwill, Adam G ^a   Frisbee, Jefferson C ^a  

^a WEST VIRGINIA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Metabolic syndrome; Microcirculation; Oxidant stress; Vasculopathy

Indexed keywords

ADVANCED GLYCATION END PRODUCT; ANGIOTENSIN II; C REACTIVE PROTEIN; CD36 ANTIGEN; CD40 ANTIGEN; CHEMOKINE RECEPTOR CCR2; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; CYTOCHROME P450 2C9; ENDOTHELIAL NITRIC OXIDE SYNTHASE; FATTY ACID; GLUCOSE; GLUCOSE TRANSPORTER 4; INSULIN RECEPTOR SUBSTRATE 1; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 1BETA; INTERLEUKIN 6; LEPTIN; LIPOXYGENASE; MONOCYTE CHEMOTACTIC PROTEIN 1; MYELOPEROXIDASE; NITRIC OXIDE; OXIDIZED LOW DENSITY LIPOPROTEIN; PLASMINOGEN ACTIVATOR INHIBITOR 1; POLYOL; REACTIVE OXYGEN METABOLITE; TUMOR NECROSIS FACTOR ALPHA; UNINDEXED DRUG; VASCULAR CELL ADHESION MOLECULE 1; XANTHINE OXIDASE;

ADAPTATION; AUTOOXIDATION; BLOOD VESSEL REACTIVITY; BLOOD VESSEL TONE; BLOOD VESSEL WALL; CYTOKINE RELEASE; ENDOTHELIAL DYSFUNCTION; HUMAN; INFLAMMATION; INSULIN DEPENDENT DIABETES MELLITUS; METABOLIC SYNDROME X; MITOCHONDRIAL MEMBRANE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; REVIEW; SKELETAL MUSCLE MICROVASCULOPATHY; VASCULAR DISEASE; VASCULAR ENDOTHELIUM; VASCULAR RESISTANCE; VASCULARIZATION; VASOCONSTRICTION; VASODILATATION;

ANIMALS; DIABETES MELLITUS, TYPE 2; HUMANS; INFLAMMATION; METABOLIC SYNDROME X; MICROCIRCULATION; MICROVESSELS; MUSCLE, SKELETAL; NITRIC OXIDE; OXIDATIVE STRESS; REACTIVE OXYGEN SPECIES; RISK FACTORS; VASCULAR DISEASES;

EID: 84865639708     PISSN: 15371891     EISSN: 18793649     Source Type: Journal    
DOI: 10.1016/j.vph.2012.07.002     Document Type: Review

References (158)

1. Akaogi J., Yamada H., Kuroda Y., Nacionales D.C., Reeves W.H., Satoh M. Prostaglandin E2 receptors EP2 and EP4 are up-regulated in peritoneal macrophages and joints of pristane-treated mice and modulate TNF-alpha and IL-6 production. J. Leukoc. Biol. 2004, 76(1):227-236. (July).
2. Alderton W.K., Cooper C.E., Knowles R.G. Nitric oxide synthases: structure, function and inhibition. Biochem. J. 2001, 357(Pt 3):593-615. (August 1).
3. American Heart Association Overweight and obesity - statistics Internet 2009; available at: URL, Accessed October 18, 2009. http://www.americanheart.org/presenter.jhtml?identifier=3000947.
4. Barnett P.A., Gonzalez R.G., Chylack L.T., Cheng H.M. The effect of oxidation on sorbitol pathway kinetics. Diabetes 1986, 35(4):426-432. (April).
5. Basta G., Schmidt A.M., De C.R. Advanced glycation end products and vascular inflammation: implications for accelerated atherosclerosis in diabetes. Cardiovasc. Res. 2004, 63(4):582-592. (September 1).
6. Baynes J.W., Thorpe S.R. Role of oxidative stress in diabetic complications: a new perspective on an old paradigm. Diabetes 1999, 48(1):1-9. (January).
7. Beny J.L., von der Weid P.Y. Hydrogen peroxide: an endogenous smooth muscle cell hyperpolarizing factor. Biochem. Biophys. Res. Commun. 1991, 176(1):378-384. (April 15).
8. Bouanane S., Benkalfat N.B., Baba Ahmed F.Z., et al. Time course of changes in serum oxidant/antioxidant status in overfed obese rats and their offspring. Clin Sci (Lond) 2009, 116(8):669-680. (April).
9. Bracci P.M. Obesity and pancreatic cancer: overview of epidemiologic evidence and biologic mechanisms. Mol. Carcinog. 2012, 51(1):53-63. (January).
10. Bucala R., Tracey K.J., Cerami A. Advanced glycosylation products quench nitric oxide and mediate defective endothelium-dependent vasodilatation in experimental diabetes. J. Clin. Invest. 1991, 87(2):432-438. (February).
11. Busik J.V., Mohr S., Grant M.B. Hyperglycemia-induced reactive oxygen species toxicity to endothelial cells is dependent on paracrine mediators. Diabetes 2008, 57(7):1952-1965. (July).
12. Butler R., Morris A.D., Belch J.J., Hill A., Struthers A.D. Allopurinol normalizes endothelial dysfunction in type 2 diabetics with mild hypertension. Hypertension 2000, 35(3):746-751. (March).
13. Cardona F., Tunez I., Tasset I., Montilla P., Collantes E., Tinahones F.J. Fat overload aggravates oxidative stress in patients with the metabolic syndrome. Eur J Clin Invest 2008, 38(7):510-515. (July).
14. Caro A.A., Cederbaum A.I. Role of cytochrome P450 in phospholipase A2- and arachidonic acid-mediated cytotoxicity. Free Radic. Biol. Med. 2006, 40(3):364-375. (February 1).
15. Chance B., Sies H., Boveris A. Hydroperoxide metabolism in mammalian organs. Physiol. Rev. 1979, 59(3):527-605. (July).
16. Chavakis E., Dernbach E., Hermann C., Mondorf U.F., Zeiher A.M., Dimmeler S. Oxidized LDL inhibits vascular endothelial growth factor-induced endothelial cell migration by an inhibitory effect on the Akt/endothelial nitric oxide synthase pathway. Circulation 2001, 103(16):2102-2107. (April 24).
17. Chen J., Huang L., Song M., Yu S., Gao P., Jing J. C-reactive protein upregulates receptor for advanced glycation end products expression and alters antioxidant defenses in rat endothelial progenitor cells. J. Cardiovasc. Pharmacol. 2009, 53(5):359-367. (May).
18. Cheng Z.J., Jiang Y.F., Ding H., Severson D., Triggle C.R. Vascular dysfunction in type 2 diabetic TallyHo mice: role for an increase in the contribution of PGH2/TxA2 receptor activation and cytochrome p450 products. Can. J. Physiol. Pharmacol. 2007, 85(3-4):404-412. (March).
19. Codoner-Franch P., Pons-Morales S., Boix-Garcia L., Valls-Belles V. Oxidant/antioxidant status in obese children compared to pediatric patients with type 1 diabetes mellitus. Pediatr Diabetes 2009, (August 4).
20. Coffey M.J., Natarajan R., Chumley P.H., et al. Catalytic consumption of nitric oxide by 12/15-lipoxygenase: inhibition of monocyte soluble guanylate cyclase activation. Proc. Natl. Acad. Sci. U. S. A. 2001, 98(14):8006-8011. (July 3).
21. Cominacini L., Pasini A.F., Garbin U., et al. Oxidized low density lipoprotein (ox-LDL) binding to ox-LDL receptor-1 in endothelial cells induces the activation of NF-kappaB through an increased production of intracellular reactive oxygen species. J. Biol. Chem. 2000, 275(17):12633-12638. (April 28).
22. Corda S., Laplace C., Vicaut E., Duranteau J. Rapid reactive oxygen species production by mitochondria in endothelial cells exposed to tumor necrosis factor-alpha is mediated by ceramide. Am J Respir Cell Mol Biol 2001, 24(6):762-768. (June).
23. Cosentino F., Hishikawa K., Katusic Z.S., Luscher T.F. High glucose increases nitric oxide synthase expression and superoxide anion generation in human aortic endothelial cells. Circulation 1997, 96(1):25-28. (July 1).
24. Csiszar A., Ungvari Z. Endothelial dysfunction and vascular inflammation in type 2 diabetes: interaction of AGE/RAGE and TNF-alpha signaling. Am. J. Physiol. Heart Circ. Physiol. 2008, 295(2):H475-H476. (August).
25. Davis B., Zou M.H. CD40 ligand-dependent tyrosine nitration of prostacyclin synthase in vivo. Circulation 2005, 112(14):2184-2192. (October 4).
26. De T.B., Smith L.H., Vaughan D.E. Plasminogen activator inhibitor-1: a common denominator in obesity, diabetes and cardiovascular disease. Curr. Opin. Pharmacol. 2005, 5(2):149-154. (April).
27. Demirbag R., Yilmaz R., Gur M., et al. DNA damage in metabolic syndrome and its association with antioxidative and oxidative measurements. Int. J. Clin. Pract. 2006, 60(10):1187-1193. (October).
28. Deshpande S.S., Angkeow P., Huang J., Ozaki M., Irani K. Rac1 inhibits TNF-alpha-induced endothelial cell apoptosis: dual regulation by reactive oxygen species. FASEB J. 2000, 14(12):1705-1714. (September).
29. Dorman R.B., Wunder C., Saba H., Shoemaker J.L., Millan-Crow L.A., Brock R.W. NAD(P)H oxidase contributes to the progression of remote hepatic parenchymal injury and endothelial dysfunction, but not microvascular perfusion deficits. Am. J. Physiol. Gastrointest. Liver Physiol. 2006, 290(5):G1025-G1032. (May).
30. Doughan A.K., Harrison D.G., Dikalov S.I. Molecular mechanisms of angiotensin II-mediated mitochondrial dysfunction: linking mitochondrial oxidative damage and vascular endothelial dysfunction. Circ. Res. 2008, 102(4):488-496. (February 29).
31. Du Y., Smith M.A., Miller C.M., Kern T.S. Diabetes-induced nitrative stress in the retina, and correction by aminoguanidine. J. Neurochem. 2002, 80(5):771-779. (March).
32. Du X., Edelstein D., Obici S., Higham N., Zou M.H., Brownlee M. Insulin resistance reduces arterial prostacyclin synthase and eNOS activities by increasing endothelial fatty acid oxidation. J. Clin. Invest. 2006, 116(4):1071-1080. (April).
33. 2, vascular endothelial growth factor and receptors in the retina of the BBZ/Wor diabetic rat. Free Radic. Biol. Med. 2000, 28(1):91-101. (January 1).
34. El-Remessy A.B., Bou-Mohamed G., Caldwell R.W., Caldwell R.B. High glucose-induced tyrosine nitration in endothelial cells: role of eNOS uncoupling and aldose reductase activation. Invest Ophthalmol Vis Sci 2003, 44(7):3135-3143. (July).
35. Endemann D.H., Schiffrin E.L. Nitric oxide, oxidative excess, and vascular complications of diabetes mellitus. Curr Hypertens Rep 2004, 6(2):85-89. (April).
36. Eringa E.C., Bakker W., Smulders Y.M., Serne E.H., Yudkin J.S., Stehouwer C.D. Regulation of vascular function and insulin sensitivity by adipose tissue: focus on perivascular adipose tissue. Microcirculation 2007, 14(4-5):389-402. (June).
37. Ervin R.B. Prevalence of metabolic syndrome among adults 20years of age and over, by sex, age, race and ethnicity, and body mass index: United States, 2003-2006. National Health Statistics Reports 2009, 5:13. (May).
38. Faulds M.H., Hlman-Wright K. Metabolic diseases and cancer risk. Curr. Opin. Oncol. 2012, 24(1):58-61. (January).
39. Feng L., Xia Y., Garcia G.E., Hwang D., Wilson C.B. Involvement of reactive oxygen intermediates in cyclooxygenase-2 expression induced by interleukin-1, tumor necrosis factor-alpha, and lipopolysaccharide. J. Clin. Invest. 1995, 95(4):1669-1675. (April).
40. Fleming I., Michaelis U.R., Bredenkotter D., et al. Endothelium-derived hyperpolarizing factor synthase (cytochrome P450 2C9) is a functionally significant source of reactive oxygen species in coronary arteries. Circ. Res. 2001, 88(1):44-51. (January 19).
41. Folcik V.A., Nivar-Aristy R.A., Krajewski L.P., Cathcart M.K. Lipoxygenase contributes to the oxidation of lipids in human atherosclerotic plaques. J. Clin. Invest. 1995, 96(1):504-510. (July).
42. Frisbee J.C., Stepp D.W. Impaired NO-dependent dilation of skeletal muscle arterioles in hypertensive diabetic obese Zucker rats. Am. J. Physiol. Heart Circ. Physiol. 2001, 281(3):H1304-H1311. (September).
43. Frisbee J.C., Hollander J.M., Brock R.W., Yu H.G., Boegehold M.A. Integration of skeletal muscle resistance arteriolar reactivity for perfusion responses in the metabolic syndrome. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2009, 296(6):R1771-R1782. (June).
44. Gabbay K.H. The sorbitol pathway and the complications of diabetes. N. Engl. J. Med. 1973, 288(16):831-836. (April 19).
45. Gendron M.E., Thorin-Trescases N., Villeneuve L., Thorin E. Aging associated with mild dyslipidemia reveals that COX-2 preserves dilation despite endothelial dysfunction. Am. J. Physiol. Heart Circ. Physiol. 2007, 292(1):H451-H458. (January).
46. Gersch C., Palii S.P., Kim K.M., Angerhofer A., Johnson R.J., Henderson G.N. Inactivation of nitric oxide by uric acid. Nucleosides Nucleotides Nucleic Acids 2008, 27(8):967-978. (August).
47. Gharavi N.M., Baker N.A., Mouillesseaux K.P., et al. Role of endothelial nitric oxide synthase in the regulation of SREBP activation by oxidized phospholipids. Circ. Res. 2006, 98(6):768-776. (March 31).
48. Ginnan R., Guikema B.J., Halligan K.E., Singer H.A., Jourd'heuil D. Regulation of smooth muscle by inducible nitric oxide synthase and NADPH oxidase in vascular proliferative diseases. Free Radic. Biol. Med. 2008, 44(7):1232-1245. (April 1).
49. Go Y.M., Levonen A.L., Moellering D., et al. Endothelial NOS-dependent activation of c-Jun NH(2)-terminal kinase by oxidized low-density lipoprotein. Am. J. Physiol. Heart Circ. Physiol. 2001, 281(6):H2705-H2713. (December).
50. Goodwill A.G., James M.E., Frisbee J.C. Increased vascular thromboxane generation impairs dilation of skeletal muscle arterioles of obese Zucker rats with reduced oxygen tension. Am. J. Physiol. Heart Circ. Physiol. 2008, 295(4):H1522-H1528. (October).
51. Goodwill A.G., Frisbee S.J., Stapleton P.A., James M.E., Frisbee J.C. Impact of chronic anticholesterol therapy on development of microvascular rarefaction in the metabolic syndrome. Microcirculation 2009, 4:1-18. (August).
52. Goossens V., Grooten J., De V.K., Fiers W. Direct evidence for tumor necrosis factor-induced mitochondrial reactive oxygen intermediates and their involvement in cytotoxicity. Proc. Natl. Acad. Sci. U. S. A. 1995, 92(18):8115-8119. (August 29).
53. Guzik T.J., Sadowski J., Guzik B., et al. Coronary artery superoxide production and nox isoform expression in human coronary artery disease. Arterioscler. Thromb. Vasc. Biol. 2006, 26(2):333-339. (February).
54. Hamuro M., Polan J., Natarajan M., Mohan S. High glucose induced nuclear factor kappa B mediated inhibition of endothelial cell migration. Atherosclerosis 2002, 162(2):277-287. (June).
55. Harrison H.E., Reece A.H., Johnson M. Decreased vascular prostacyclin in experimental diabetes. Life Sci. 1978, 23(4):351-355. (July 24).
56. Hodnett B.L., Dearman J.A., Carter C.B., Hester R.L. Attenuated PGI2 synthesis in obese Zucker rats. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2009, 296(3):R715-R721. (March).
57. Hopps E., Noto D., Caimi G., Averna M.R. A novel component of the metabolic syndrome: the oxidative stress. Nutr. Metab. Cardiovasc. Dis. 2010, 20:72-77. (September 9).
58. Hotamisligil G.S., Shargill N.S., Spiegelman B.M. Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance. Science 1993, 259(5091):87-91. (January 1).
59. Hotamisligil G.S., Arner P., Caro J.F., Atkinson R.L., Spiegelman B.M. Increased adipose tissue expression of tumor necrosis factor-alpha in human obesity and insulin resistance. J. Clin. Invest. 1995, 95(5):2409-2415. (May).
60. Hotamisligil G.S., Peraldi P., Budavari A., Ellis R., White M.F., Spiegelman B.M. IRS-1-mediated inhibition of insulin receptor tyrosine kinase activity in TNF-alpha- and obesity-induced insulin resistance. Science 1996, 271(5249):665-668. (February 2).
61. Iliff J.J., Wang R., Zeldin D.C., Alkayed N.J. Epoxyeicosanoids as mediators of neurogenic vasodilation in cerebral vessels. Am. J. Physiol. Heart Circ. Physiol. 2009, 296(5):H1352-H1363. (May).
62. Isogawa A., Yamakado M., Yano M., Shiba T. Serum superoxide dismutase activity correlates with the components of metabolic syndrome or carotid artery intima-media thickness. Diabetes Res Clin Pract 2009, 86:213-218. (October 8).
63. Jaimes E.A., Sweeney C., Raij L. Effects of the reactive oxygen species hydrogen peroxide and hypochlorite on endothelial nitric oxide production. Hypertension 2001, 38(4):877-883. (October).
64. Jaimes E.A., Tian R.X., Pearse D., Raij L. Up-regulation of glomerular COX-2 by angiotensin II: role of reactive oxygen species. Kidney Int. 2005, 68(5):2143-2153. (November).
65. Jain N., Naseem I., Ahmad J. Evaluation of DNA damage and metabolic syndrome parameters in diabetic rabbits supplemented with antioxidants. Fundam. Clin. Pharmacol. 2009, 23(2):197-205. (April).
66. Jaxa-Chamiec T., Bednarz B., Drozdowska D., et al. Antioxidant effects of combined vitamins C and E in acute myocardial infarction. The randomized, double-blind, placebo controlled, multicenter pilot Myocardial Infarction and VITamins (MIVIT) trial. Kardiol Pol 2005, 62(4):344-350. (April).
67. Jay D., Hitomi H., Griendling K.K. Oxidative stress and diabetic cardiovascular complications. Free Radic. Biol. Med. 2006, 40(2):183-192. (January 15).
68. Johnson F., Giulivi C. Superoxide dismutases and their impact upon human health. Mol Aspects Med 2005, 26(4-5):340-352. (August).
69. Kaimul A.M., Nakamura H., Masutani H., Yodoi J. Thioredoxin and thioredoxin-binding protein-2 in cancer and metabolic syndrome. Free Radic. Biol. Med. 2007, 43(6):861-868. (September 15).
70. Keaney J.F., Larson M.G., Vasan R.S., et al. Obesity and systemic oxidative stress: clinical correlates of oxidative stress in the Framingham study. Arterioscler. Thromb. Vasc. Biol. 2003, 23(3):434-439. (March 1).
71. Kim J.W., Baek B.S., Kim Y.K., et al. Gene expression of cyclooxygenase in the aging heart. J Gerontol A Biol Sci Med Sci 2001, 56(8):B350-B355. (August).
72. Kiritoshi S., Nishikawa T., Sonoda K., et al. Reactive oxygen species from mitochondria induce cyclooxygenase-2 gene expression in human mesangial cells: potential role in diabetic nephropathy. Diabetes 2003, 52(10):2570-2577. (October).
73. Knight S.F., Imig J.D. Obesity, insulin resistance, and renal function. Microcirculation 2007, 14(4-5):349-362. (June).
74. Knott H.M., Brown B.E., Davies M.J., Dean R.T. Glycation and glycoxidation of low-density lipoproteins by glucose and low-molecular mass aldehydes. Formation of modified and oxidized particles. Eur J Biochem 2003, 270(17):3572-3582. (September).
75. Knudson J.D., Dincer U.D., Bratz I.N., Sturek M., Dick G.M., Tune J.D. Mechanisms of coronary dysfunction in obesity and insulin resistance. Microcirculation 2007, 14(4-5):317-338. (June).
76. Koshida R., Ou J., Matsunaga T., et al. Angiostatin: a negative regulator of endothelial-dependent vasodilation. Circulation 2003, 107(6):803-806. (February 18).
77. Kugiyama K., Kerns S.A., Morrisett J.D., Roberts R., Henry P.D. Impairment of endothelium-dependent arterial relaxation by lysolecithin in modified low-density lipoproteins. Nature 1990, 344(6262):160-162. (March 8).
78. Kuzuya M., Ando F., Iguchi A., Shimokata H. Glutathione peroxidase 1 Pro198Leu variant contributes to the metabolic syndrome in men in a large Japanese cohort. Am. J. Clin. Nutr. 2008, 87(6):1939-1944. (June).
79. Lalla E., Lamster I.B., Drury S., Fu C., Schmidt A.M. Hyperglycemia, glycoxidation and receptor for advanced glycation endproducts: potential mechanisms underlying diabetic complications, including diabetes-associated periodontitis. Periodontol. 2000, 23:50-62. (June 2000).
80. Lassegue B., Clempus R.E. Vascular NAD(P)H oxidases: specific features, expression, and regulation. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2003, 285(2):R277-R297. (August).
81. Lemos H.P., Grespan R., Vieira S.M., et al. Prostaglandin mediates IL-23/IL-17-induced neutrophil migration in inflammation by inhibiting IL-12 and IFNgamma production. Proc. Natl. Acad. Sci. U. S. A. 2009, 106(14):5954-5959. (April 7).
82. Li D., Mehta J.L. Antisense to LOX-1 inhibits oxidized LDL-mediated upregulation of monocyte chemoattractant protein-1 and monocyte adhesion to human coronary artery endothelial cells. Circulation 2000, 101(25):2889-2895. (June 27).
83. Li H., Junk P., Huwiler A., et al. Dual effect of ceramide on human endothelial cells: induction of oxidative stress and transcriptional upregulation of endothelial nitric oxide synthase. Circulation 2002, 106(17):2250-2256. (October 22).
84. Li D., Liu L., Chen H., Sawamura T., Mehta J.L. LOX-1, an oxidized LDL endothelial receptor, induces CD40/CD40L signaling in human coronary artery endothelial cells. Arterioscler. Thromb. Vasc. Biol. 2003, 23(5):816-821. (May 1).
85. Liao J.K., Shin W.S., Lee W.Y., Clark S.L. Oxidized low-density lipoprotein decreases the expression of endothelial nitric oxide synthase. J. Biol. Chem. 1995, 270(1):319-324. (January 6).
86. Liguori A., Abete P., Hayden J.M., et al. Effect of glycaemic control and age on low-density lipoprotein susceptibility to oxidation in diabetes mellitus type 1. Eur Heart J 2001, 22(22):2075-2084. (November).
87. 2 is the transferrable factor mediating flow-induced dilation in human coronary arterioles. Circ. Res. 2011, 108(5):566-573. (March 4).
88. Lorenzi M. The polyol pathway as a mechanism for diabetic retinopathy: attractive, elusive, and resilient. Exp Diabetes Res 2007, 2007:61038.
89. Manabe I. Chronic inflammation links cardiovascular, metabolic and renal diseases. Circ. J. 2011, 75(12):2739-2748.
90. Mangin E.L., Kugiyama K., Nguy J.H., Kerns S.A., Henry P.D. Effects of lysolipids and oxidatively modified low density lipoprotein on endothelium-dependent relaxation of rabbit aorta. Circ. Res. 1993, 72(1):161-166. (January).
91. Marvar P.J., Hammer L.W., Boegehold M.A. Hydrogen peroxide-dependent arteriolar dilation in contracting muscle of rats fed normal and high salt diets. Microcirculation 2007, 14(8):779-791. (November).
92. Matsuo K., Mizoue T., Tanaka K., et al. Association between body mass index and the colorectal cancer risk in Japan: pooled analysis of population-based cohort studies in Japan. Ann. Oncol. 2012, 23(2):479-490. (February).
93. McCabe T.J., Fulton D., Roman L.J., Sessa W.C. Enhanced electron flux and reduced calmodulin dissociation may explain "calcium-independent" eNOS activation by phosphorylation. J. Biol. Chem. 2000, 275(9):6123-6128. (March 3).
94. Mehta J.L., Sanada N., Hu C.P., et al. Deletion of LOX-1 reduces atherogenesis in LDLR knockout mice fed high cholesterol diet. Circ. Res. 2007, 100(11):1634-1642. (June 8).
95. Miura H., Bosnjak J.J., Ning G., Saito T., Miura M., Gutterman D.D. Role for hydrogen peroxide in flow-induced dilation of human coronary arterioles. Circ. Res. 2003, 92(2):e31-e40. (February 7).
96. Mokdad A.H., Ford E.S., Bowman B.A., et al. Prevalence of obesity, diabetes, and obesity-related health risk factors, 2001. JAMA 2003, 289(1):76-79. (January 1).
97. Morre D.M., Lenaz G., Morre D.J. Surface oxidase and oxidative stress propagation in aging. J. Exp. Biol. 2000, 203(Pt 10):1513-1521. (May).
98. Nagareddy P.R., Xia Z., McNeill J.H., MacLeod K.M. Increased expression of iNOS is associated with endothelial dysfunction and impaired pressor responsiveness in streptozotocin-induced diabetes. Am. J. Physiol. Heart Circ. Physiol. 2005, 289(5):H2144-H2152. (November).
99. Napoli C., Lerman L.O., de N.F., Loscalzo J., Ignarro L.J. Glycoxidized low-density lipoprotein downregulates endothelial nitricoxide synthase in human coronary cells. J. Am. Coll. Cardiol. 2002, 40(8):1515-1522. (October 16).
100. Nayeem M.A., Poloyac S.M., Falck J.R., et al. Role of CYP epoxygenases in A2A AR-mediated relaxation using A2A AR-null and wild-type mice. Am. J. Physiol. Heart Circ. Physiol. 2008, 295(5):H2068-H2078. (November).
101. Nishikawa T., Edelstein D., Du X.L., et al. Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage. Nature 2000, 404(6779):787-790. (April 13).
102. Nishikawa T., Kukidome D., Sonoda K., et al. Impact of mitochondrial ROS production in the pathogenesis of insulin resistance. Diabetes Res Clin Pract 2007, 77(Suppl. 1):S161-S164. (September).
103. Oates P.J. Polyol pathway and diabetic peripheral neuropathy. Int. Rev. Neurobiol. 2002, 50:325-392.
104. Oberley L.W. Free radicals and diabetes. Free Radic. Biol. Med. 1988, 5(2):113-124.
105. O'Donnell V.B., Coles B., Lewis M.J., Crews B.C., Marnett L.J., Freeman B.A. Catalytic consumption of nitric oxide by prostaglandin H synthase-1 regulates platelet function. J. Biol. Chem. 2000, 275(49):38239-38244. (December 8).
106. O'Donnell R.W., Johnson D.K., Ziegler L.M., DiMattina A.J., Stone R.I., Holland J.A. Endothelial NADPH oxidase: mechanism of activation by low-density lipoprotein. Endothelium 2003, 10(6):291-297.
107. Paravicini T.M., Touyz R.M. NADPH oxidases, reactive oxygen species, and hypertension: clinical implications and therapeutic possibilities. Diabetes Care 2008, 31(Suppl. 2):S170-S180. (February).
108. Peluffo G., Radi R. Biochemistry of protein tyrosine nitration in cardiovascular pathology. Cardiovasc. Res. 2007, 75(2):291-302. (July 15).
109. Phillips S.A., Sylvester F.A., Frisbee J.C. Oxidant stress and constrictor reactivity impair cerebral artery dilation in obese Zucker rats. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2005, 288(2):R522-R530. (February).
110. Portanova J.P., Zhang Y., Anderson G.D., et al. Selective neutralization of prostaglandin E2 blocks inflammation, hyperalgesia, and interleukin 6 production in vivo. J Exp Med 1996, 184(3):883-891. (September 1).
111. Qiao L.Y., Zhande R., Jetton T.L., Zhou G., Sun X.J. In vivo phosphorylation of insulin receptor substrate 1 at serine 789 by a novel serine kinase in insulin-resistant rodents. J. Biol. Chem. 2002, 277(29):26530-26539. (July 19).
112. Ramana K.V., Chandra D., Srivastava S., Bhatnagar A., Srivastava S.K. Nitric oxide regulates the polyol pathway of glucose metabolism in vascular smooth muscle cells. FASEB J. 2003, 17(3):417-425. (March).
113. Renier G. Lectin-like oxidized low-density lipoprotein receptor-1 (LOX-1), a relevant target for diabetic vasculopathy?. Cardiovasc Hematol Disord Drug Targets 2008, 8(3):203-211. (September).
114. Rudich A., Tirosh A., Potashnik R., Hemi R., Kanety H., Bashan N. Prolonged oxidative stress impairs insulin-induced GLUT4 translocation in 3T3-L1 adipocytes. Diabetes 1998, 47(10):1562-1569. (October).
115. Saitoh S., Zhang C., Tune J.D., et al. Hydrogen peroxide: a feed-forward dilator that couples myocardial metabolism to coronary blood flow. Arterioscler. Thromb. Vasc. Biol. 2006, 26(12):2614-2621. (December).
116. Saitoh S., Kiyooka T., Rocic P., et al. Redox-dependent coronary metabolic dilation. Am. J. Physiol. Heart Circ. Physiol. 2007, 293(6):H3720-H3725. (December).
117. Sakurai T., Tsuchiya S. Superoxide production from nonenzymatically glycated protein. FEBS Lett. 1988, 236(2):406-410. (August 29).
118. Sakurai K., Cominacini L., Garbin U., et al. Induction of endothelin-1 production in endothelial cells via co-operative action between CD40 and lectin-like oxidized LDL receptor (LOX-1). J. Cardiovasc. Pharmacol. 2004, 44(Suppl. 1):S173-S180. (November).
119. Schiffrin E.L., Touyz R.M. From bedside to bench to bedside: role of renin-angiotensin-aldosterone system in remodeling of resistance arteries in hypertension. Am. J. Physiol. Heart Circ. Physiol. 2004, 287(2):H435-H446. (August).
120. Schneider C., Pratt D.A., Porter N.A., Brash A.R. Control of oxygenation in lipoxygenase and cyclooxygenase catalysis. Chem. Biol. 2007, 14(5):473-488. (May).
121. Schulze-Osthoff K., Bakker A.C., Vanhaesebroeck B., Beyaert R., Jacob W.A., Fiers W. Cytotoxic activity of tumor necrosis factor is mediated by early damage of mitochondrial functions. Evidence for the involvement of mitochondrial radical generation. J. Biol. Chem. 1992, 267(8):5317-5323. (March 15).
122. Schulze-Osthoff K., Beyaert R., Vandevoorde V., Haegeman G., Fiers W. Depletion of the mitochondrial electron transport abrogates the cytotoxic and gene-inductive effects of TNF. EMBO J. 1993, 12(8):3095-3104. (August).
123. Shimizu K., Muramatsu M., Kakegawa Y., et al. Role of prostaglandin H2 as an endothelium-derived contracting factor in diabetic state. Diabetes 1993, 42(9):1246-1252. (September).
124. Singer G., Granger D.N. Inflammatory responses underlying the microvascular dysfunction associated with obesity and insulin resistance. Microcirculation 2007, 14(4-5):375-387. June.
125. Skyrme-Jones R.A., O'Brien R.C., Berry K.L., Meredith I.T. Vitamin E supplementation improves endothelial function in type I diabetes mellitus: a randomized, placebo-controlled study. J. Am. Coll. Cardiol. 2000, 36(1):94-102. (July).
126. Stalker T.J., Skvarka C.B., Scalia R. A novel role for calpains in the endothelial dysfunction of hyperglycemia. FASEB J. 2003, 17(11):1511-1513. (August).
127. Stapleton P.A., James M.E., Goodwill A.G., Frisbee J.C. Obesity and vascular dysfunction. Pathophysiology 2008, 15(2):79-89. (August).
128. Stapleton P.A., Goodwill A.G., James M.E., Brock R.W., Frisbee J.C. Hypercholesterolemia and microvascular dysfunction: interventional strategies. J Inflamm (Lond) 2010, 7:54.
129. Stephens J.W., Khanolkar M.P., Bain S.C. The biological relevance and measurement of plasma markers of oxidative stress in diabetes and cardiovascular disease. Atherosclerosis 2009, 202(2):321-329. (February).
130. Stern D.M., Yan S.D., Yan S.F., Schmidt A.M. Receptor for advanced glycation endproducts (RAGE) and the complications of diabetes. Ageing Res Rev 2002, 1(1):1-15. (February).
131. Subbiah M.T., Dietemeyer D. Altered synthesis of prostaglandins in platelet and aorta from spontaneously diabetic Wistar rats. Biochem Med 1980, 23(2):231-235. (April).
132. Szwergold B.S., Kappler F., Brown T.R. Identification of fructose 3-phosphate in the lens of diabetic rats. Science 1990, 247(4941):451-454. (January 26).
133. Talior I., Yarkoni M., Bashan N., Eldar-Finkelman H. Increased glucose uptake promotes oxidative stress and PKC-delta activation in adipocytes of obese, insulin-resistant mice. Am. J. Physiol. Endocrinol. Metab. 2003, 285(2):E295-E302. (August).
134. The American Heart Association What is the metabolic syndrome? Internet 2009; available at: URL, Accessed June 1, 2009. http://www.americanheart.org/presenter.jhtml?identifier=4756.
135. Thomas S.R., Chen K., Keaney J.F. Hydrogen peroxide activates endothelial nitric-oxide synthase through coordinated phosphorylation and dephosphorylation via a phosphoinositide 3-kinase-dependent signaling pathway. J. Biol. Chem. 2002, 277(8):6017-6024. (February 22).
136. Thomas S.R., Schulz E., Keaney J.F. Hydrogen peroxide restrains endothelium-derived nitric oxide bioactivity - role for iron-dependent oxidative stress. Free Radic. Biol. Med. 2006, 41(4):681-688. (August 15).
137. Thomas S.R., Witting P.K., Drummond G.R. Redox control of endothelial function and dysfunction: molecular mechanisms and therapeutic opportunities. Antioxid Redox Signal 2008, 10(10):1713-1765. (October).
138. Topal G., Brunet A., Millanvoye E., et al. Homocysteine induces oxidative stress by uncoupling of NO synthase activity through reduction of tetrahydrobiopterin. Free Radic. Biol. Med. 2004, 36(12):1532-1541. (June 15).
139. Torchinsky A., Toder V. TNFalpha in the pathogenesis of diabetes-induced embryopathies: functions and targets. Rev Diabet Stud 2007, 4(4):200-209.
140. Tretter L., Dam-Vizi V. Inhibition of Krebs cycle enzymes by hydrogen peroxide: a key role of [alpha]-ketoglutarate dehydrogenase in limiting NADH production under oxidative stress. J. Neurosci. 2000, 20(24):8972-8979. (December 15).
141. Tziomalos K., Hare J.M. Role of xanthine oxidoreductase in cardiac nitroso-redox imbalance. Front. Biosci. 2009, 14:237-262.
142. van Dam P.S., van Asbeck B.S., Erkelens D.W., Marx J.J., Gispen W.H., Bravenboer B. The role of oxidative stress in neuropathy and other diabetic complications. Diabetes Metab Rev 1995, 11(3):181-192. (October).
143. Vasquez-Vivar J., Kalyanaraman B., Martasek P. The role of tetrahydrobiopterin in superoxide generation from eNOS: enzymology and physiological implications. Free. Radic. Res. 2003, 37(2):121-127. (February).
144. Venugopal S.K., Devaraj S., Yuhanna I., Shaul P., Jialal I. Demonstration that C-reactive protein decreases eNOS expression and bioactivity in human aortic endothelial cells. Circulation 2002, 106(12):1439-1441. (September 17).
145. Vergnani L., Hatrik S., Ricci F., et al. Effect of native and oxidized low-density lipoprotein on endothelial nitric oxide and superoxide production: key role of l-arginine availability. Circulation 2000, 101(11):1261-1266. (March 21).
146. Vlassara H. The AGE-receptor in the pathogenesis of diabetic complications. Diabetes Metab Res Rev 2001, 17(6):436-443. (November).
147. Wautier M.P., Chappey O., Corda S., Stern D.M., Schmidt A.M., Wautier J.L. Activation of NADPH oxidase by AGE links oxidant stress to altered gene expression via RAGE. Am. J. Physiol. Endocrinol. Metab. 2001, 280(5):E685-E694. (May).
148. Wiersma J.J., Meuwese M.C., van Miert J.N., et al. Diabetes mellitus type 2 is associated with higher levels of myeloperoxidase. Med Sci Monit 2008, 14(8):CR406-CR410. (August).
149. World Health Organization Obesity and overweight. What are overweight and obesity? Internet 2006 September; available at: URL, Accessed July 10, 2009. http://www.who.int/mediacentre/factsheets/fs311/en/.
150. Xu J., Xie Z., Reece R., Pimental D., Zou M.H. Uncoupling of endothelial nitric oxidase synthase by hypochlorous acid: role of NAD(P)H oxidase-derived superoxide and peroxynitrite. Arterioscler. Thromb. Vasc. Biol. 2006, 26(12):2688-2695. (December).
151. Yamagishi S.I., Edelstein D., Du X.L., Kaneda Y., Guzman M., Brownlee M. Leptin induces mitochondrial superoxide production and monocyte chemoattractant protein-1 expression in aortic endothelial cells by increasing fatty acid oxidation via protein kinase A. J. Biol. Chem. 2001, 276(27):25096-25100. (July 6).
152. Yan S.D., Schmidt A.M., Anderson G.M., et al. Enhanced cellular oxidant stress by the interaction of advanced glycation end products with their receptors/binding proteins. J. Biol. Chem. 1994, 269(13):9889-9897. (April 1).
153. Yla-Herttuala S., Luoma J., Viita H., Hiltunen T., Sisto T., Nikkari T. Transfer of 15-lipoxygenase gene into rabbit iliac arteries results in the appearance of oxidation-specific lipid-protein adducts characteristic of oxidized low density lipoprotein. J. Clin. Invest. 1995, 95(6):2692-2698. (June).
154. Zhang L., Zalewski A., Liu Y., et al. Diabetes-induced oxidative stress and low-grade inflammation in porcine coronary arteries. Circulation 2003, 108(4):472-478. (July 29).
155. Zhang C., Yang J., Jennings L.K. Leukocyte-derived myeloperoxidase amplifies high-glucose-induced endothelial dysfunction through interaction with high-glucose-stimulated, vascular non-leukocyte-derived reactive oxygen species. Diabetes 2004, 53(11):2950-2959. (November).
156. Zhang H., Zhang J., Ungvari Z., Zhang C. Resveratrol improves endothelial function: role of TNF{alpha} and vascular oxidative stress. Arterioscler. Thromb. Vasc. Biol. 2009, 29(8):1164-1171. (August).
157. Zou M.H., Shi C., Cohen R.A. Oxidation of the zinc-thiolate complex and uncoupling of endothelial nitric oxide synthase by peroxynitrite. J. Clin. Invest. 2002, 109(6):817-826. (March).
158. Zou M.H., Hou X.Y., Shi C.M., Nagata D., Walsh K., Cohen R.A. Modulation by peroxynitrite of Akt- and AMP-activated kinase-dependent Ser1179 phosphorylation of endothelial nitric oxide synthase. J. Biol. Chem. 2002, 277(36):32552-32557. (September 6).